Jiangsu Hengrui Medicine Co., Ltd. is principally engaged in the manufacturing and distribution of pharmaceutical tablets, injections and raw materials. The Company is also involved in medicine commerce. The Company mainly provides antineoplastic drugs, drugs for the treatment of cardiovascular disease, drugs for surgery, drugs for the treatment of endocrine, antibiotics, big infusions and others, including calcium levofolinate for injection, cyclophosphamide for injection, etoposide for soft capsules, calcium folinate tablets, irbesartan tablets, bupivacaine hydrochloride for injection, levofloxacin hydrochloride tablets, glucose injections and sodium chloride injections, among others. The Company distributes its products primarily in domestic market.